Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 62.70B | 66.68B | 64.61B | 50.61B | 45.06B |
Gross Profit | 10.03B | 10.54B | 11.35B | 8.64B | 8.68B |
EBITDA | 4.80B | 5.69B | 6.02B | 4.08B | 3.88B |
Net Income | 1.53B | 2.43B | 2.60B | 1.37B | 1.23B |
Balance Sheet | |||||
Total Assets | 50.12B | 46.43B | 46.50B | 39.69B | 36.22B |
Cash, Cash Equivalents and Short-Term Investments | 241.00M | 214.00M | 411.00M | 198.00M | 177.00M |
Total Debt | 10.73B | 7.90B | 11.09B | 7.60B | 5.01B |
Total Liabilities | 21.69B | 22.10B | 23.81B | 18.64B | 16.30B |
Stockholders Equity | 28.42B | 24.33B | 22.70B | 21.05B | 19.93B |
Cash Flow | |||||
Free Cash Flow | -1.83B | 3.72B | -3.13B | -2.38B | 2.27B |
Operating Cash Flow | 3.69B | 6.77B | -533.00M | 292.00M | 3.85B |
Investing Cash Flow | -5.76B | -2.46B | -2.24B | -2.41B | -2.12B |
Financing Cash Flow | 2.10B | -4.51B | 2.98B | 2.14B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥16.60B | 10.81 | 2.81% | -5.97% | -37.27% | ||
69 Neutral | ¥14.02B | 15.13 | 1.70% | 4.25% | -18.59% | ||
66 Neutral | £10.46B | 8.44 | 3.35% | 302.87% | -1.42% | 18.13% | |
63 Neutral | ¥13.60B | 16.27 | 1.90% | 0.59% | -15.61% | ||
62 Neutral | ¥14.22B | 25.71 | 1.96% | 4.72% | 20.48% | ||
57 Neutral | ¥14.90B | 42.39 | 2.18% | 1.59% | -57.66% | ||
57 Neutral | ¥13.71B | 24.88 | 0.32% | -2.04% | ― |